Ignite Creation Date:
2024-05-05 @ 11:26 PM
Last Modification Date:
2024-10-26 @ 10:33 AM
Study NCT ID:
NCT01327989
Status:
COMPLETED
Last Update Posted:
2017-01-27
First Post:
2010-10-12
Brief Title:
Solitaire FR Thrombectomy for Acute Revascularisation
Sponsor:
Medtronic Neurovascular Clinical Affairs
Organization:
Medtronic Neurovascular Clinical Affairs
Study Overview
Official Title:
STAR Solitaire FR Thrombectomy for Acute Revascularisation
Status:
COMPLETED
Status Verified Date:
2016-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
STAR
Brief Summary:
The objective of this study was to obtain prospective clinical data on the safety and efficacy of the Solitaire FR device for patients diagnosed with acute ischemic stroke
Detailed Description:
The Study was a multi-center single-arm prospective observational evaluation The Solitaire FR Device has been certified for CE mark This protocol evaluated the safety and efficacy of the Solitaire FR Device when used in routine practice and according to its Instructions for Use
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None